Partnerships, Licensing, Investments, and M&A Deals & Trends in Pharmaceuticals (Q4, 2018) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Partnerships,
Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4
2018” report has been added to ResearchAndMarkets.com’s
offering.

This report is an essential source of data and trend analysis on
partnerships, licensing, mergers and acquisitions (M&As) and financings
in the pharmaceuticals industry.

The report provides detailed information on partnership and licensing
transactions, M&As, equity/debt offerings, private equity, and venture
financing registered in the pharmaceuticals industry in Q4 2018. The
report portrays detailed comparative data on the number of deals and
their value in the last five quarters, subdivided by deal types, various
therapy areas, and geographies. Additionally, the report provides
information on the top financial advisory firms in the pharmaceuticals
industry.

Scope

• Analysis of the market trends for the pharmaceutical industry in the
  global arena.
• Review of deal trends in the cardiovascular, central nervous system,
  dermatology, ear nose throat disorders, gastrointestinal, genito
  urinary system and sex hormones, hematological disorders, hormonal
  disorders, immunology, infectious disease, male health, metabolic
  disorders, mouth and dental disorders, musculoskeletal, oncology,
  ophthalmology, respiratory, toxicology, and women’s health segments.
• Analysis of partnerships, licensing, M&As, equity/debt offerings,
  private equity, and venture financing deals in the pharmaceutical
  industry.
• Analysis of therapy areas which are very active in terms of venture
  capital financing, partnerships, licensing agreements, equity/debt
  offerings, and M&As.
• Analysis of deals based on different payment modes, including upfront
  and milestone payments, primarily in partnerships and licensing
  agreements in the pharmaceutical industry.
• Analysis of partnership and licensing deals based on clinical stage of
  development of products.
• Summary of the pharmaceutical deals globally in the five quarters.
• Information on the top deals happened in the pharmaceutical industry.
• Geographies covered include – North America, Europe, Asia Pacific,
  South & Central America, and the Middle East & Africa.
• League tables of financial advisors in M&As and equity/debt offerings.
  This includes key advisors such as Morgan Stanley, Credit Suisse, and
  Goldman Sachs.

Reasons to Buy

• Enhance your decision making capability in a more rapid and time
  sensitive manner.
• Find out the major deal performing segments for investments in your
  industry.
• Evaluate the types of companies which are entering into partnership or
  licensing agreements; divesting and acquiring assets.
• Identify companies that are aggressively looking to raise capital in
  the market
• Evaluate niche therapy areas that are receiving majority of the
  upfront and milestone payments in the pharmaceutical industry.
• Identify the key venture capitalists, who are financing the
  pharmaceutical and biotech companies.
• Evaluate the clinical development stages where majority of the
  partnerships and licensing agreements are happening.
• Do deals with an understanding of how competitors are financed, and
  the mergers and partnerships that have shaped the pharmaceutical
  industry.
• Identify growth segments and opportunities in each region within the
  industry.
• Look for key financial advisors where you are planning to raise
  capital from the market or for acquisitions within the industry.

Key Topics Covered

1 List of Tables & Figures

2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2018

3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type

4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2018

5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2018

6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area

7 Deal Summary by Geography

8 Pharmaceuticals & Healthcare, Global, Top Advisors

For more information about this report visit https://www.researchandmarkets.com/r/ysedg4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceuticals